Guidance on the Management of Clinical Trial during the COVID-19 (Coronavirus) pandemic

Due to the corona crisis the source data verification for the majority of the clinical trials conducted is severely hampered. ...

Publication | 23-02-2021

A: Relevant legislation

Publication | 01-10-2020

B: Clinical investigations involving the use of medical devices – regime

Publication | 01-10-2020

Requirements (re)start clinical trials

Report | 25-08-2020

Coronavirus (COVID-19): impact on the conduct of clinical trials under the Medical Research Involving Human Subjects Act (WMO)

Publication | 25-08-2020

Greater cohesion and continuity needed in the care sector for people with chronic mental health problems

Publication | 24-08-2020

GLP domestic test facilities

Publication | 30-07-2020

IGJ information about clinical trials in the Netherlands

Publication | 25-05-2020

Coronavirus (COVID-19): impact on the conduct of clinical trials under the Medical Research Involving Human Subjects Act (WMO)

The information below is valid during the COVID-19 pandemic until the situation is normalised and this is stated on the website ...

Publication | 12-05-2020

Instruction to register the supply of alternative medical devices

A manufacturer, authorised representative, distributor, or importer can register the supply of an alternative medical device with ...

Publication | 10-04-2020